Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fred Bunz

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
The Journal of Biological Chemistry|March 26, 2003
The Chk2 tumor suppressor is not required for p53 responses in human cancer cellsPrasad V Jallepalli, Christoph Lengauer, Bert Vogelstein, et al.
The Journal of Biological Chemistry|October 10, 2014
A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signalingJon H Chung, Andrew R Larsen, Evan Chen, et al.
Antioxidants & Redox Signaling|May 8, 2010
Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistanceAnju Singh, Manish Bodas, Nobunao Wakabayashi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 10, 2020
For HIPEC, synergistic effects of hyperthermia and doxorubicin are optimal when simultaneously combinedAnirudh Sharma, Michelle A Rudek, Preethi Korangath, et al.
Nucleic Acids Research|October 11, 2005
Improved methods for the generation of human gene knockout and knockin cell linesOzlem Topaloglu, Paula J Hurley, Ozlem Yildirim, et al.
Nucleic Acids Research|September 12, 2008
Epitope tagging of endogenous genes in diverse human cell linesJung-Sik Kim, Challice Bonifant, Fred Bunz, et al.
Radiation Research|October 15, 2024
Effect of Ultrahigh Dose Rate on Biomolecular Radiation DamageDaniel Sforza, Fred Bunz, John Wong, et al.
Blood|April 16, 2005
Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac developmentElias T Zambidis, Bruno Peault, Tea Soon Park, et al.
Molecular Cancer Therapeutics|November 16, 2011
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalDeborah Wilsker, Jon H Chung, Ivan Pradilla, et al.
Neuro-Oncology|September 26, 2014
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesisRen-Yuan Bai, Verena Staedtke, Charles M Rudin, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
The Journal of Biological Chemistry|March 26, 2003
The Chk2 tumor suppressor is not required for p53 responses in human cancer cellsPrasad V Jallepalli, Christoph Lengauer, Bert Vogelstein, et al.
The Journal of Biological Chemistry|October 10, 2014
A PTCH1 homolog transcriptionally activated by p53 suppresses Hedgehog signalingJon H Chung, Andrew R Larsen, Evan Chen, et al.
Antioxidants & Redox Signaling|May 8, 2010
Gain of Nrf2 function in non-small-cell lung cancer cells confers radioresistanceAnju Singh, Manish Bodas, Nobunao Wakabayashi, et al.
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|April 10, 2020
For HIPEC, synergistic effects of hyperthermia and doxorubicin are optimal when simultaneously combinedAnirudh Sharma, Michelle A Rudek, Preethi Korangath, et al.
Nucleic Acids Research|October 11, 2005
Improved methods for the generation of human gene knockout and knockin cell linesOzlem Topaloglu, Paula J Hurley, Ozlem Yildirim, et al.
Nucleic Acids Research|September 12, 2008
Epitope tagging of endogenous genes in diverse human cell linesJung-Sik Kim, Challice Bonifant, Fred Bunz, et al.
Radiation Research|October 15, 2024
Effect of Ultrahigh Dose Rate on Biomolecular Radiation DamageDaniel Sforza, Fred Bunz, John Wong, et al.
Blood|April 16, 2005
Hematopoietic differentiation of human embryonic stem cells progresses through sequential hematoendothelial, primitive, and definitive stages resembling human yolk sac developmentElias T Zambidis, Bruno Peault, Tea Soon Park, et al.
Molecular Cancer Therapeutics|November 16, 2011
Targeted mutations in the ATR pathway define agent-specific requirements for cancer cell growth and survivalDeborah Wilsker, Jon H Chung, Ivan Pradilla, et al.
Neuro-Oncology|September 26, 2014
Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesisRen-Yuan Bai, Verena Staedtke, Charles M Rudin, et al.
Pageof 6